跳至主要内容
临床试验/ISRCTN32652461
ISRCTN32652461已完成未知

Cervical Ripening at Home or In-Hospital - prospective cohort study and process evaluation (CHOICE study)

niversity of Edinburgh0 个研究点目标入组 25,677 人开始时间: 2020年7月10日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25,677

研究概览

简要总结

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33947741/ (added 06/05/2021)

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • Current inclusion criteria as of 17/11/2022:
  • Observational study:
  • For data collection:
  • 1. Gestation 37+0 weeks or more
  • 2. Undergoing IOL
  • For primary analysis:
  • 1. Gestation of 39+0 weeks or more
  • Qualitative study:
  • For questionnaire-based survey:
  • 1. Gestation 37+0 weeks or more
  • 2. Undergoing IOL
  • For case studies:
  • 1. Gestation of 37+0 weeks or more
  • Previous inclusion criteria:
  • Observational study:
  • For data collection:
  • 1. Gestation 37+0 weeks or more
  • 2. Undergoing IOL
  • For primary analysis:
  • 1. Gestation of 39+0 weeks or more
  • Qualitative study:
  • For questionnaire-based survey:
  • 1. Gestation 39+0 weeks or more
  • 2. Undergoing IOL
  • For case studies:
  • 1. Gestation of 39+0 weeks or more

排除标准

  • Current exclusion criteria as of 17/11/2022:
  • Observational study:
  • For data collection:
  • 1. Opted out of data provision (checkbox)
  • Applied for primary analysis:
  • 1. Grand multiparity (6 or more previous pregnancies)
  • 2. Previous caesarean section
  • 3. Antepartum stillbirth (before cervical ripening initiated)
  • 4. Class III obesity at booking (BMI 40 kg/m2 or more)
  • 5. Prelabour rupture of membranes documented as primary or other indication for IOL (prolonged ROM; SROM; ?SROM)
  • 6. Maternal, fetal or medical condition that would/could preclude home cervical ripening documented as primary or other indication for IOL
  • 7. Maternal conditions: proteinuria; hypertension; antepartum haemorrhage; diabetes; obstetric cholestasis; past obstetric history; pre-eclampsia; PIH/PET (not defined); PIH; PET; thrombophilia
  • 8. Fetal conditions: oligohydramnios; reduced liquor volume; macrosomia; intrauterine growth restriction (IUGR); static growth; congenital fetal anomaly; polyhydramnios; abnormal CTG/Doppler; breech; reduced fetal movements; termination of pregnancy for fetal anomaly
  • Qualitative study:
  • For case studies:
  • 1. Women who did not have IOL at 37+0 weeks of gestation
  • 2. Women who had IOL for medical reasons
  • 3. Women who had an elective cesarean section
  • 4. Women who have experienced intrauterine death, stillbirth or neonatal death
  • Previous exclusion criteria:
  • Observational study:
  • For data collection:
  • 1. Opted out of data provision (checkbox)
  • Applied for primary analysis:
  • 1. Grand multiparity (6 or more previous pregnancies)
  • 2. Previous caesarean section
  • 3. Antepartum stillbirth (before cervical ripening initiated)
  • 4. Class III obesity at booking (BMI 40 kg/m2 or more)
  • 5. Prelabour rupture of membranes documented as primary or other indication for IOL (prolonged ROM; SROM; ?SROM)
  • 6. Maternal, fetal or medical condition that would/could preclude home cervical ripening documented as primary or other indication for IOL
  • 7. Maternal conditions: proteinuria; hypertension; antepartum haemorrhage; diabetes; obstetric cholestasis; past obstetric history; pre-eclampsia; PIH/PET (not defined); PIH; PET; thrombophilia
  • 8. Fetal conditions: oligohydramnios; reduced liquor volume; macrosomia; intrauterine growth restriction (IUGR); static growth; congenital fetal anomaly; polyhydramnios; abnormal CTG/Doppler; breech; reduced fetal movements; termination of pregnancy for fetal anomaly
  • Qualitative study:
  • For case studies:
  • 1. Women who did not have IOL at 39+0 weeks of gestation
  • 2. Women who had IOL for medical reasons
  • 3. Women who had an elective cesarean section
  • 4. Women who have experienced intrauterine death, stillbirth or neonatal death

研究者

发起方
niversity of Edinburgh

相似试验